.Attribute Medication, Posted online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec got FDA authorization after an adverse test, which highlights the various difficulties and difficulties of medication advancement in this particular setup.